SG49631A1 - Hepatitis b vaccine - Google Patents
Hepatitis b vaccineInfo
- Publication number
- SG49631A1 SG49631A1 SG1996001902A SG1996001902A SG49631A1 SG 49631 A1 SG49631 A1 SG 49631A1 SG 1996001902 A SG1996001902 A SG 1996001902A SG 1996001902 A SG1996001902 A SG 1996001902A SG 49631 A1 SG49631 A1 SG 49631A1
- Authority
- SG
- Singapore
- Prior art keywords
- pct
- mhbsag
- fragment
- sec
- vaccine
- Prior art date
Links
- SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 title 1
- 229940124736 hepatitis-B vaccine Drugs 0.000 title 1
- 239000012634 fragment Substances 0.000 abstract 2
- 241000700721 Hepatitis B virus Species 0.000 abstract 1
- 102000008300 Mutant Proteins Human genes 0.000 abstract 1
- 108010021466 Mutant Proteins Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9401987A GB9401987D0 (en) | 1994-02-02 | 1994-02-02 | Modified nucleic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG49631A1 true SG49631A1 (en) | 1998-06-15 |
Family
ID=10749735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996001902A SG49631A1 (en) | 1994-02-02 | 1995-02-02 | Hepatitis b vaccine |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5856084A (fr) |
| EP (1) | EP0741745B1 (fr) |
| JP (1) | JP3812949B2 (fr) |
| KR (1) | KR100370341B1 (fr) |
| CN (1) | CN1057774C (fr) |
| AT (1) | ATE310014T1 (fr) |
| AU (1) | AU693154B2 (fr) |
| CA (1) | CA2182375A1 (fr) |
| DE (1) | DE69534617T2 (fr) |
| ES (1) | ES2258767T3 (fr) |
| GB (1) | GB9401987D0 (fr) |
| MX (1) | MX9603182A (fr) |
| NZ (1) | NZ278937A (fr) |
| PL (1) | PL315784A1 (fr) |
| SG (1) | SG49631A1 (fr) |
| WO (1) | WO1995021189A1 (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5595739A (en) * | 1993-05-07 | 1997-01-21 | Abbott Laboratories | Hepatitis B virus mutants, reagents and methods for detection |
| GB9608626D0 (en) * | 1996-04-25 | 1996-07-03 | Univ College Of London | Hepatitis b monoclonal antibodies |
| EP0919568A1 (fr) | 1997-12-01 | 1999-06-02 | Sorin Diagnostics S.r.l. | Mutants de fuite des antigènes de surface du virus de l'hépatite B |
| US6787142B2 (en) | 2001-04-30 | 2004-09-07 | Government Of Republic Of Singapore | Mutant human hepatitis B viral strain and uses thereof |
| US6558675B1 (en) * | 1998-06-19 | 2003-05-06 | Government Of Republic Of Singapore | Mutant human hepatitis B viral strain and uses thereof |
| AU756858B2 (en) * | 1998-06-19 | 2003-01-23 | Government Of The Republic Of Singapore | A vaccine-induced hepatitis B viral strain and uses thereof |
| FR2803599B1 (fr) * | 2000-01-06 | 2004-11-19 | Inst Nat Sante Rech Med | Nouveau virus mute de l'hepatite b, ses constituants nucleiques et proteiques et leurs applications |
| KR100368756B1 (ko) * | 2000-02-01 | 2003-01-24 | 주식회사 엘지생명과학 | 비형 간염 표면 항원에 대한 항체 진단 시약의 제조방법,이를 이용하여 수득되는 비형 간염 항원에 대한 항체 진단시약 및 비형 간염 바이러스 항체 진단 시약 |
| CA2486420C (fr) * | 2002-06-14 | 2014-04-15 | Gen-Probe Incorporated | Compositions et methodes de detection du virus de l'hepatite b |
| CN100355777C (zh) * | 2003-02-10 | 2007-12-19 | 文洪模 | 乙型肝炎病毒pre－S突变蛋白及其制备方法与应用 |
| US8242238B2 (en) * | 2003-06-20 | 2012-08-14 | Dade Behring Marburg Gmbh | Surface protein (HBsAg) variant of the hepatitis B virus |
| CA2580620C (fr) * | 2004-09-22 | 2014-04-22 | Advanced Life Science Institute, Inc. | Methode de detection de l'antigene s du virus de l'hepatite b |
| JP4948783B2 (ja) * | 2005-05-18 | 2012-06-06 | シスメックス株式会社 | 抗ＨＢｓモノクローナル抗体 |
| CN100520409C (zh) * | 2005-09-06 | 2009-07-29 | 珠海丽珠试剂有限公司 | 新型乙型肝炎病毒表面抗原确认试剂盒 |
| EP3312189A1 (fr) | 2011-04-21 | 2018-04-25 | Ionis Pharmaceuticals, Inc. | Modulation de l'expression du virus de l'hépatite b (vhb) |
| WO2012171205A1 (fr) * | 2011-06-16 | 2012-12-20 | 华为技术有限公司 | Procédé et dispositif de pointage par antenne réseau à commande de phase et antenne réseau à commande de phase |
| EP3274051A4 (fr) | 2015-03-25 | 2018-08-22 | IGM Biosciences A/S | Molécules de liaison à un antigène du virus de l'hépatite b multivalentes et utilisations de celles-ci |
| AU2020357502A1 (en) | 2019-09-30 | 2022-05-19 | Gilead Sciences, Inc. | HBV vaccines and methods treating HBV |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9007024D0 (en) * | 1990-03-29 | 1990-05-30 | Imperial College | Novel vaccine |
| CA2067003A1 (fr) * | 1991-04-29 | 1992-10-30 | Peter J. Kniskern | Vaccin mutant de variante d'antigene de surface d'hbv |
| US5595739A (en) * | 1993-05-07 | 1997-01-21 | Abbott Laboratories | Hepatitis B virus mutants, reagents and methods for detection |
-
1994
- 1994-02-02 GB GB9401987A patent/GB9401987D0/en active Pending
-
1995
- 1995-02-02 EP EP95907092A patent/EP0741745B1/fr not_active Expired - Lifetime
- 1995-02-02 SG SG1996001902A patent/SG49631A1/en unknown
- 1995-02-02 DE DE69534617T patent/DE69534617T2/de not_active Expired - Fee Related
- 1995-02-02 CA CA002182375A patent/CA2182375A1/fr not_active Abandoned
- 1995-02-02 PL PL95315784A patent/PL315784A1/xx unknown
- 1995-02-02 WO PCT/GB1995/000208 patent/WO1995021189A1/fr active IP Right Grant
- 1995-02-02 JP JP52045495A patent/JP3812949B2/ja not_active Expired - Fee Related
- 1995-02-02 NZ NZ278937A patent/NZ278937A/en unknown
- 1995-02-02 AT AT95907092T patent/ATE310014T1/de not_active IP Right Cessation
- 1995-02-02 ES ES95907092T patent/ES2258767T3/es not_active Expired - Lifetime
- 1995-02-02 AU AU15426/95A patent/AU693154B2/en not_active Ceased
- 1995-02-02 CN CN95191963A patent/CN1057774C/zh not_active Expired - Fee Related
- 1995-02-02 MX MX9603182A patent/MX9603182A/es not_active IP Right Cessation
- 1995-02-02 US US08/500,914 patent/US5856084A/en not_active Expired - Fee Related
- 1995-02-02 KR KR1019960704148A patent/KR100370341B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH09508284A (ja) | 1997-08-26 |
| ES2258767T3 (es) | 2006-09-01 |
| AU693154B2 (en) | 1998-06-25 |
| JP3812949B2 (ja) | 2006-08-23 |
| CN1143373A (zh) | 1997-02-19 |
| GB9401987D0 (en) | 1994-03-30 |
| AU1542695A (en) | 1995-08-21 |
| EP0741745A1 (fr) | 1996-11-13 |
| EP0741745B1 (fr) | 2005-11-16 |
| CA2182375A1 (fr) | 1995-08-10 |
| MX9603182A (es) | 1997-05-31 |
| KR100370341B1 (ko) | 2003-04-11 |
| CN1057774C (zh) | 2000-10-25 |
| PL315784A1 (en) | 1996-12-09 |
| NZ278937A (en) | 1998-06-26 |
| US5856084A (en) | 1999-01-05 |
| WO1995021189A1 (fr) | 1995-08-10 |
| DE69534617D1 (en) | 2005-12-22 |
| ATE310014T1 (de) | 2005-12-15 |
| DE69534617T2 (de) | 2006-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69534617D1 (en) | Hepatitis b-impfstoff | |
| GR3017804T3 (en) | Hepatitis b vaccine. | |
| IL102687A0 (en) | Method for enhancing immunogenicity | |
| PT101052A (pt) | Proteinas hibridas uteis na preparacao de vacinas | |
| IL134392A0 (en) | Vaccine against hpv | |
| PT81338A (en) | Antigens particularly envelope antigens of the virus of lymphadenopathies and of the acquired immuno-depressive syndrome and virus process for producing virus envelope antigens in the preparation of immunogenic compositions or for the diagnosis of the presence of antibodies against this virus | |
| AU668094B2 (en) | Seroreactive regions on HPV 16 proteins E1 and E2 | |
| WO2002032923A3 (fr) | Formulations ameliorees utilisant des complexes peptides-proteines de choc thermique/de stress | |
| GR3031889T3 (en) | Lipopeptide inducing T-cytotoxic lymphocytes and their use as vaccines. | |
| NZ295056A (en) | Hepatitis virus e strain, recombinant proteins thereof, use in diagnostic methods and vaccines | |
| EP1326895B8 (fr) | Anticorps monoclonaux diriges contre des virus de l'hepatite b | |
| AU6461594A (en) | Induction of protection against viral infection | |
| CA2286399A1 (fr) | Proteines de recombinaison d'une souche pakistanaise de l'hepatite e et leurs utilisation dans des methodes diagnostiques et des vaccins | |
| WO2002051865A3 (fr) | Antigenes proteiques inducteurs d'anticorps neutralisant le virus vih | |
| NZ532271A (en) | Peptide mimics of conserved gonococcal epitopes and methods and compositions using them | |
| WO2000018429A3 (fr) | Vaccin a base d'haemophilus somnus attenue | |
| GR3036125T3 (en) | Recombinant proteins having the immunoreactivity of Hepatitis B virus e antigens (HBeAg), method for their production and their application in immunoassays and as vaccines. |